Daniel Ramirez leads the engagement of LEO Pharma with Digital Skin health startups as a Managing Director of the LEO Innovation lab Ventures team. Daniel is based in Palo Alto, CA and currently focuses on technologies that can diagnose, monitor and predict skin diseases, the digitization of the Clinical trials process, precision medicine and Novel drug discovery tools.

Prior to LEO Pharma, Daniel held leadership roles in the Coca Cola Company within the Innovation and New Beverages areas and supported corporations to solve strategic issues as a consultant with McKinsey & Company. Daniel attained an MBA degree from IESE Business School in Barcelona, Spain.